» Articles » PMID: 18172731

Tumor-associated Lymphangiogenesis Correlates with Lymph Node Metastases and Prognosis in Hilar Cholangiocarcinoma

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2008 Jan 4
PMID 18172731
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Tumor-associated lymphangiogenesis has been shown to promote nodal spread and is of prognostic significance in some tumor entities. Currently, nothing is known about the impact of lymphangiogenesis on progression and prognosis in hilar cholangiocarcinoma.

Methods: We analyzed tissue specimens of normal liver and hilar cholangiocarcinoma (n = 60) by immunohistochemistry using the lymphendothelial-specific antibody D2-40 and subsequently quantified lymphatic microvessel density (LVD). The LVD was correlated with clinicopathological characteristics and recurrence pattern of the tumors as well as patients' survival.

Results: In contrast to the low abundance of lymphatic vessels in nontransformed liver tissue, we found an induction of lymphangiogenesis in hilar cholangiocarcinoma. Tumors with a high LVD (34 out of 60) had a significant higher incidence of lymph node involvement (p < 0.001), perivascular (p = 0.017), and perineural (p = 0.033) lymphangiosis and local recurrence (p < 0.001). Furthermore, a high LVD was identified to be a significant overall (three-year: 24.4% versus 90.5%; five-year: 7.0% versus 76.4%; p < 0.001) and disease-free (three-year: 8.3% versus 76.6%; five-year: 5.9% versus 61.4%; p < 0.001) survival disadvantage, with LVD representing an independent prognostic factor for survival (p < 0.001) in the multivariate analysis.

Conclusions: Lymphangiogenesis is associated with increased frequency of tumor cells in lymphatics and lymph nodes in hilar cholangiocarcinoma. The prognostic importance of tumor-associated lymphangiogenesis was reflected by LVD serving as an independent prognostic factor. In addition, lymphangiogenesis may represent a potential target in the development of new therapeutic approaches in hilar cholangiocarcinoma.

Citing Articles

Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis.

Li J, Liang Y, Wang Q, Li Y, Chen X, Luo W Front Immunol. 2025; 15():1519999.

PMID: 39840048 PMC: 11747820. DOI: 10.3389/fimmu.2024.1519999.


Tumor-associated lymphatic vessel density is a reliable biomarker for prognosis of esophageal cancer after radical resection: a systemic review and meta-analysis.

Li J, Wang Q, Liang Y, Chen X, Luo W, Li Y Front Immunol. 2024; 15:1453482.

PMID: 39372418 PMC: 11449706. DOI: 10.3389/fimmu.2024.1453482.


Tumor microenvironment and immunology of cholangiocarcinoma.

Cadamuro M, Fabris L, Zhang X, Strazzabosco M Hepatoma Res. 2024; 8.

PMID: 39301518 PMC: 11412615. DOI: 10.20517/2394-5079.2021.140.


Histopathological growth pattern and vessel co-option in intrahepatic cholangiocarcinoma.

Li Z, Nguyen Canh H, Takahashi K, Le Thanh D, Nguyen Thi Q, Yang R Med Mol Morphol. 2024; 57(3):200-217.

PMID: 38960952 PMC: 11343874. DOI: 10.1007/s00795-024-00392-1.


Tumor lymphangiogenesis index reveals the immune landscape and immunotherapy response in lung adenocarcinoma.

Yang W, Wu Z, Cai S, Li Z, Wang W, Wu J Front Immunol. 2024; 15:1354339.

PMID: 38638428 PMC: 11024352. DOI: 10.3389/fimmu.2024.1354339.